"In 2025, we aspire to achieve: Revenue of at least $2 billion, reflecting a 20%+ top-line annual growth rate; Adjusted EBITDA margins of approximately 25%, representing about 500 basis points of improvement over three years; Strong cash generation, with adjusted free cash flow conversion on Adjusted EBITDA of at least 60%, as we continue to invest to support global scale; Reduced dilution related to stock-based compensation. We continue to work through already granted equity vesting and exercises which can result in uneven annual levels of dilution, and we are targeting a CAGR for annual dilution of approximately 3% for 2025 and beyond as we work through already granted equity vesting and exercises."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AXON:
- Axon 2022 Revenue Grows 38% to $1.2 Billion
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Axon downgraded to Outperform from Strong Buy at Raymond James
- Axon price target raised to $235 from $195 at JMP Securities
- Fly Insider: Clear Channel, Jabil among notable insider trades this week
